Sebacia Inc. is a clinical-stage, private medical device company dedicated to creating breakthrough topical therapies for the treatment of dermatological conditions affecting millions of people. Sebacia's goal is to provide a better alternative to the daily use of topical and systemic drugs currently available for the treatment of acne. Sebacia's patented microparticles technology was invented at Rice University, and the proprietary dermatology applications were further developed with researchers from the Wellman Center of Photomedicine at Massachusetts General Hospital.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/25/15 | $22,000,000 | Series C |
Accuitive Medical Ventures Domain Associates Partners Innovation Fund Versant Ventures | undisclosed |
| 07/25/17 | $20,000,000 | Series D |
Accuitive Medical Ventures Domain Associates Partners HealthCare Innovation Versant Ventures | undisclosed |
